You searched for "imaging"
Pioneering accessible technology conference returns to Glasgow in 2025
RNIB Scotland’s Inclusive Design for Sustainability (IDS) Conference is set to return to Glasgow Science Centre on 17 and 18 March 2025, bringing together global tech giants and accessibility advocates to explore the future of inclusive design. The event, which...OpenEyes – Community edition
Moving to an electronic patient record (EPR) is all the rage these days, even in the District General Hospitals (DGHs). When I am not writing these articles I work in one such hospital. At Bolton Foundation Trust we deployed OpenEyes...Major survey calls for new ideas on how to reinvent post diagnostic support for blind and partially sighted people
The Royal National Institute of Blind People (RNIB) is launching a new research study to better understand post-diagnostic support across the sight loss sector. People who have experienced being diagnosed with a sight condition know it’s not always easy to...The results of the last survey Jun22
Thank you once more for your time in answering the latest survey. The first question relates to the number of staff required for a routine cataract list. There was a big variance in practice. Some of us are luckier than...
Blinking and driving
Spontaneous blinking is dependent on cognitive processes and is regulated by a central pacemaker that is highly sensitive to the attention demands and cognitive workload of the visual task in hand. There is evidence of a variability in the frequency...OSA signs further 10 year deal with 100% Optical
The OSA and Media 10, owners of 100% Optical, have signed a further ten-year agreement to work together. This follows the three-year agreement which has been in place since the closure of Optrafair. The securing of this long-term relationship between...
Therapeutic options for advanced cutaneous basal (BCC) and squamous cell carcinomas (SCC)
This article discusses the use of topical and systemic therapy in the management of advanced periocular tumours. It focuses on those that have gained United States Food and Drug Administration approval; namely imiquimod, vismodegib, sonidegib, pembrolizumab and cemiplimab. Imiquimod is...
The compendium to clinical evidence in DMO treatment
This review article summarises the current evidence base in the treatment options for diabetic macular oedema (DMO). The authors have included many real-world data studies that provided valuable insights into the optimal management of DMO. The authors argue that these...The rare link between uveitis and tattoos
Health experts are warning about a rare but potentially serious condition known as tattoo-associated uveitis, after a rise in reported cases in Australia. The condition occurs when the immune system reacts to certain toxic chemicals found within certain tattoo inks...Global Lens on Eyecare
CBM Ireland presents Global Lens on Eyecare
